Jakob Dupont, SVP & CMO at OncoMed Pharma, holds 38.74K shares in Pyxis Oncology (Ticker: PYXS), holds 290.79K shares in Atara Biotherapeutics (Ticker: ATRA), holds 0.00 shares in Gossamer Bio (Ticker: GOSS).

See the Hottest Stocks Based on Insider Trading >

Jakob Dupont
OncoMed Pharma (OMED)
SVP & CMO

Ranked #30,539 out of 98,624 Corporate Insiders

Profitable Transactions

2 out of 2 Profitable Transactions

Average Return

+47.90%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

54.64%

ATRA

45.36%

PYXS

0.00%

GOSS

A breakdown of Jakob Dupont's holdings

See the Top Stocks by Insiders

Insider Roles

Atara Biotherapeutics
(ATRA)

EVP, Head of R&D

Pyxis Oncology
(PYXS)

Director

Gossamer Bio
(GOSS)

CMO

Roles that Jakob Dupont holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

OncoMed Pharma
(OMED)

Rating:Informative Sell

Date:Jan 08, 2016 - Jan 08, 2017

Return:+57.80%

The most profitable trade made by Jakob Dupont

See the Latest Stocks Traded by Insiders

Jakob Dupont's Trading History

OMED

OncoMed Pharma

Oct 11, 2016

―

Uninformative Buy

―

$18.37K

GOSS

Gossamer Bio

Dec 31, 2019

CMO

Informative Sell

631.53K

$0.00

ATRA

Atara Biotherapeutics

Mar 06, 2023

EVP, Head of R&D

Uninformative Sell

18.37K

$200.65K

APGN

Apexigen

―

PYXS

Pyxis Oncology

Mar 28, 2024

Director

Uninformative Buy

―

$166.59K

List of latest transactions for each holding click on a transaction to see Jakob Dupont's performance on stock

See All Insider Trading from Today

Jakob Dupont insider profile FAQ

What is the percentage of profitable transactions made by Jakob Dupont?

The percentage of profitable transactions made by Jakob Dupont is 100%.

What is the average return per transaction made by Jakob Dupont?

The average return per transaction made by Jakob Dupont is 47.90%.

What stocks does Jakob Dupont hold?

Jakob Dupont holds: OMED, GOSS, ATRA, APGN, PYXS stocks.

What was Jakob Dupont’s latest transaction?

Jakob Dupont latest transaction was an Uninformative Buy of ―.

What was Jakob Dupont's most profitable transaction?

Jakob Dupont’s most profitable transaction was an Informative Sell of OMED stock on January 8, 2016. The return on the trade was 57.80%.

What is Jakob Dupont's role in OncoMed Pharma?

Jakob Dupont's role in OncoMed Pharma is SVP & CMO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Jakob Dupont Insider Profile

Jakob Dupont OncoMed Pharma (OMED)SVP & CMO